Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Coenzyme Q10 Phospholipidic Vesicular Formulations for Treatment of Androgenic Alopecia: Ex Vivo Permeation and Clinical Appraisal

research Coenzyme Q10 phospholipidic vesicular formulations for treatment of androgenic alopecia:ex vivopermeation and clinical appraisal

10 citations , May 2021 in “Expert Opinion on Drug Delivery”

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

New Small Molecules in Dermatology: For Autoimmunity, Inflammation, and Beyond

research New small molecules in dermatology: for the autoimmunity, inflammation and beyond

9 citations , May 2023 in “Inflammation Research”

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

research Progressive expression of PPARGC1α is associated with hair miniaturization in androgenetic alopecia

8 citations , June 2019 in “Scientific Reports”

Increased PPARGC1α relates to hair thinning in common baldness.

research Imbalanced redox dynamics induce fibroblast senescence leading to impaired stem cell pools and skin aging

7 citations , March 2025 in “Free Radical Biology and Medicine”

Imbalanced redox dynamics cause skin aging by damaging fibroblasts and stem cells.

research Severe metabolic disorders coexisting with Werner syndrome: a case report

6 citations , October 2020 in “Endocrine journal”

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

research Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment

4 citations , January 2024 in “International Journal of Environment Agriculture and Biotechnology”

Women with PCOS can lead healthy lives with proper diagnosis and treatment.

research HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms

2 citations , January 2014 in “Elsevier eBooks”

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

← Previous page